Science & Tech
Bharat Biotech arm Nucelion partners VeGen Bio to make dual-target CAR-T therapy VL-2511 in India
Nucelion Therapeutics and VeGen Bio have agreed to transfer technology for, manufacture and commercialise VL-2511 in India. It is an autologous CAR-T therapy that targets both BCMA (B-cell maturation antigen) and CD19, a...